2011Medical Journal of Chinese People's HealthRequires access

A control study of Risperidone oral solution in treating chronic schizophrenia patients

Hui Huang

Open publisher page 0 citations

Abstract

Objective:To compare the efficacy and safety between Risperidone oral solution and Clozapine in the treatment of chronic schizophrenia patients.Methods:90 patients with chronic schizophrenia were randomly divided into study group(n=45) and control group(n=45),treated with Risperidone oral solution and Clozapine respectively for 8 weeks.The positive and negative syndomly scale(PANSS),Clinical Global Impression(CGI) was used to assess the therapeutic efficacy.The treatment emergent symptom scale(TESS) was used to assess side effect.Results: Risperidone oral solution was as effective as Clozapine for the treatment of chronic schizophrenia(P0.05).The marked improvement rate of the former was 70.5% and the later was 73.8%.The incidence rate of adverse effect was 50% in Risperidone oral solution group and that was 90.48% in Clozapine group.Significant differences were observed between them(P0.05).Conclusions: Risperidone oral solution is an effective and safe drug in the treatment of chronic schizophrenia.Its side effects were fewer.

About this research paper

What this paper is about

Objective:To compare the efficacy and safety between Risperidone oral solution and Clozapine in the treatment of chronic schizophrenia patients.Methods:90 patients with chronic schizophrenia were randomly divided into study group(n=45) and control group(n=45),treated with Risperidone oral solution and Clozapine respectively for 8 weeks.The positive and negative syndomly scale(PANSS),Clinical Global Impression(CGI) was used to assess the therapeutic efficacy.The treatment emergent symptom scale(TESS) was used to assess side effect.Results: Risperidone oral solution was as effective as Clozapine for the treatment of chronic schizophrenia(P0.05).The marked improvement rate of the former was 70.5% and the later was 73.8%.The incidence rate of adverse effect was 50% in Risperidone oral solution group and that was 90.48% in Clozapine group.Significant differences were observed between them(P0.05).Conclusions: Risperidone oral solution is an effective and safe drug in the treatment of chronic schizophrenia.Its side effects were fewer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To compare the efficacy and safety between Risperidone oral solution and Clozapine in the treatment of chronic schizophrenia patients.Methods:90 patients with chronic schizophrenia were randomly divided into study group(n=45) and control group(n=45),treated with Risperidone oral solution and Clozapine respectively for 8 weeks.The positive and negative syndomly scale(PANSS),Clinical Global Impression(CGI) was used to assess the therapeutic efficacy.The treatment emergent symptom scale(TESS) was used to assess side effect.Results: Risperidone oral solution was as effective as Clozapine for the treatment of chronic schizophrenia(P0.05).The marked improvement rate of the former was 70.5% and the later was 73.8%.The incidence rate of adverse effect was 50% in Risperidone oral solution group and that was 90.48% in Clozapine group.Significant differences were observed between them(P0.05).Conclusions: Risperidone oral solution is an effective and safe drug in the treatment of chronic schizophrenia.Its side effects were fewer.

Key concepts: Risperidone, Schizophrenia (object-oriented programming), Clozapine, Clinical Global Impression, Adverse effect, Medicine, Internal medicine, Clinical efficacy

Related papers

Back to paper searchBrowse research topicsOriginal source
A control study of Risperidone oral solution in treating chronic schizophrenia patients — Research Paper | ScholarLens